Rhenman & Partners Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-244,000
| Closed | -$5.77M | – | 103 |
|
|
2019
Q3 | $5.77M | Buy |
244,000
+15,000
| +7% | +$355K | 0.72% | 52 |
|
|
2019
Q2 | $6.89M | Buy |
229,000
+79,000
| +53% | +$2.38M | 0.76% | 52 |
|
|
2019
Q1 | $3.36M | Buy |
+150,000
| New | +$3.36M | 0.39% | 65 |
|
|
2018
Q2 | – | Sell |
-39,115
| Closed | -$208K | – | 93 |
|
|
2018
Q1 | $208K | Sell |
39,115
-69,336
| -64% | -$369K | 0.03% | 92 |
|
|
2017
Q4 | $922K | Sell |
108,451
-11,246
| -9% | -$95.6K | 0.12% | 81 |
|
|
2017
Q3 | $1.75M | Buy |
+119,697
| New | +$1.75M | 0.22% | 77 |
|